VALHI INC /DE/ (VHI) Q3 2025 10-Q Quarterly Report

Filed: Nov 6, 2025Period ending Sep 30, 2025
Health Care
Industrial Inorganic ChemicalsSEC EDGAR

VALHI INC /DE/ (VHI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

VALHI INC /DE/ Q3 2025 10-Q Analysis

Management Discussion & Analysis

  • No quarterly revenue or YoY change figures provided in the goodwill discussion
  • No profitability or margin data disclosed in this section
+3 more insights

Risk Factors

  • No new or changed risk factors disclosed since 2024 Annual Report risk section
  • Most significant risks remain operational exposure in chemical markets and cyclicality of end markets
+3 more insights

VALHI INC /DE/ Q3 2025 Quarterly Financials
XBRL

Revenue

$504M

-5.6% YoY -6.8% QoQ

Net Income

-$22M

-138.6% YoY -2566.7% QoQ

Gross Margin

12.0%

-976bp YoY -242bp QoQ

Operating Margin

1.7%

-1098bp YoY -486bp QoQ

Net Margin

-4.4%

-1518bp YoY -458bp QoQ

ROE

-2.1%

Total Assets

$2.7B

EPS (Diluted)

$-0.77

-138.1% YoY -2666.7% QoQ

Operating Cash Flow

-$2M

-114.1% YoY -108.8% QoQ

Source: XBRL data from VALHI INC /DE/ Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on VALHI INC /DE/

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.